Related Experiment Video
Updated: Oct 16, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
Nitesh Gautam1, Prachi Saluja1, Marat Fudim2
1Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.
Abstract:
With the introduction of the coronavirus disease 2019 (COVID-19) mRNA vaccines, the incidence of severe infection has significantly decreased. While the vaccines have been shown to be effective and safe, there have been few case reports of acute myocarditis within 3-5 days following the second dose of the vaccine. We report a case of an elderly man who presented with acute-onset chest pain after three months of receiving the second dose of the mRNA vaccine. He was found to have acute myocarditis on cardiac magnetic resonance imaging (CMRI), which was attributed to exposure to the COVID-19 vaccine in the absence of any other risk factors. Our patient demonstrated quick resolution of symptoms and was discharged within 72 hours. We review the literature and summarize published case reports on COVID-19 vaccine-associated myocarditis. The present case report provides new evidence regarding the possible subacute presentation of myocarditis post-COVID-19 vaccine, and further highlights the favorable outcome in this newly described clinical entity.
Insights
This case report details an elderly man who developed subacute myocarditis three months after his second COVID-19 mRNA vaccine dose. Fortunately, he experienced a rapid recovery, highlighting a favorable outcome for this rare vaccine side effect.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- The widespread adoption of COVID-19 mRNA vaccines has drastically reduced severe infections.
- While generally safe and effective, rare cases of acute myocarditis have been reported post-vaccination, typically within days of the second dose.
Observation:
- An elderly male presented with chest pain three months after his second COVID-19 mRNA vaccine dose.
- Cardiac magnetic resonance imaging confirmed acute myocarditis.
- No other risk factors for myocarditis were identified, leading to vaccine association.
Findings:
- This case suggests a possible subacute presentation of myocarditis following COVID-19 vaccination, occurring months after the second dose.
- The patient experienced a swift resolution of symptoms and was discharged within 72 hours.
- Literature review and case summary of COVID-19 vaccine-associated myocarditis are included.
Implications:
- This report expands the understanding of the temporal relationship between COVID-19 vaccination and myocarditis.
- It highlights a potentially favorable prognosis for vaccine-associated myocarditis, even with a delayed presentation.
- Further research into the mechanisms and long-term outcomes of vaccine-induced myocarditis is warranted.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy I: Introduction and Classification